News

The Wilmer Eye Institute of the Johns Hopkins University School of Medicine was to hold its 28th annual Current Concepts in Ophthalmology Course on March 14-18.

Findings from a retrospective analysis including 81,715 consecutive LASIK-treated eyes provide no evidence after 12 to 24 months of follow-up that a "thin cornea" increases the risk for postoperative ectasia.

International Vision Expo East, March 16 to 20 in New York City, will showcase exhibitors from around the world and provide the opportunity to touch, learn about, and experience firsthand the many products and services available to the optical community.

The International Vision Expo East and Conference was to celebrate its 25th year, March 16 to 20, at the Jacob K. Javits Convention Center here.

Your patients may not realize that the risk for blinding eye diseases such as age-related macular degeneration (AMD) can be lessened by taking basic steps to ensure overall health. Here is some information to share with them.

The Lumbini Eye Institute and the Calabar Teaching Hospital have received $50,000 research grants from the Pediatric Cataract Initiative, a partnership of the Bausch + Lomb Early Vision Institute and Lions Clubs International Foundation that aims to prevent vision loss in children.

A team of researchers has discovered a molecular mechanism implicated in geographic atrophy that may lead to the development of ways to prevent the condition.

Sustained-release fluocinolone acetonide (Iluvien, Alimera Sciences) demonstrates statistically significant effectiveness in the treatment of diabetic macular edema (DME), according to recently released 36-month data from the FAME Study.

Attendees at the upcoming International Vision Expo and Conference can take advantage of discounted hotels and travel, as well as exclusive shopping and entertainment specials in New York City. International Vision Expo and Conference will be held March 16-20, at the Jacob K. Javits Center.

Robert Cionni, MD, a specialist in cataract surgery and LASIK in Salt Lake City, UT, was selected to Becker?s ASC Review list of the ?34 Best Ophthalmologists in America? for his leadership and involvement in nationally recognized ophthalmologic organizations.

February is ?Save Your Vision Month,? and the American Academy of Ophthalmology (AAO) is encouraging Americans over the age of 40 to make an appointment for an eye examination. According to AAO, by 2020 43 million Americans will be at risk for significant vision loss or blindness from age-related eye diseases such as cataracts, diabetic retinopathy, glaucoma, and macular degeneration?an increase of more than 50% over the current number of Americans with these diseases.

The American Academy of Ophthalmology (AAO) has distributed 360 Basic and Clinical Science Course (BCSC) sets, a complete curriculum in ophthalmology, to residency training programs in 67 developing nations through its Education Distribution Project.

Patients taking an omega-3 supplement (TheraTears Nutrition, Advanced Vision Research) had a self-reported reduction in dry eye symptoms and an increase in tear volume and tear flow compared with a group of controls who received placebos, according to a pilot trial of dry eye patients reported in the journal Cornea.

Product benefits relating to vision quality top the list of considerations when patients whose vision has been corrected select eye-care products, according to the Needs, Symptoms, Incidence, Global Eye Health Trends (NSIGHT) study.

An ophthalmic mitomycin C system (Mitosol, Mobius Therapeutics) used in the prevention of recurrence of pterygium after its surgical excision has received orphan drug designation from the FDA, according to the company.

Transitions Optical is expanding its consumer education program through a video series and retail space at upcoming PGA Tour events.

Craig Delgado began serving as president of Oasis Medical on Jan. 1.

The U.S. Patent and Trademark Office has issued a new patent to Biolase Technology covering the use of its laser technologies for treating presbyopia and hyperopia, according to the company.

Two new tools available on a proprietary OCT imaging system are designed to help physicians assess glaucoma risk and progression in their patients.

Pooled results from two prospective, multicenter, double-masked, placebo-controlled studies show a multi-modal anti-allergy product, bepotastine besilate ophthalmic solution 1.5%, provides rapid and long-lasting clinically significant improvement in allergen-induced ocular itching.

Epinastine hydrochloride ophthalmic solution 0.05% is a reliable, fast-acting treatment for patients with itching associated with allergic conjunctivitis.

Solutions to impact patient outcomes are being evaluated.

The ocular functional optical zone decreased in about one-third of eyes following wavefront-guided PRK for myopia and mixed astigmatism.

Potent activity combined with a favorable safety profile make loteprednol etabonate ophthalmic suspension 0.2% a valuable option for the management of seasonal allergic conjunctivitis.

Near-term results from a study assessing the effects of patient age on the safety and efficacy of LASIK for the treatment of myopia indicate that young adults do equally well as their older counterparts.

In the first in-human study fo human umbilical tissue-derived cells as cell-based therapy for retinal degenerative diseases, all seven patients tolerated the subretinal injection well and had no postoperative visual loss.

Frontalis suspension, the ptosis surgery of choice for poor levator function due to congenital or acquired ptosis, can be performed with synthetic materials or fascia lata allografts or autografts.

In patients undergoing LASIK with use of a femtosecond laser for flap creation, pretreatment with a hyperosmotic agent during the week before surgery significantly reduces the risk of intraoperative corneal epithelial disruption.